We are live on
!
Find out more
DekaBank Deutsche Girozentrale Portfolio holdings
AUM
$59.2B
1-Year Est. Return
26.02%
This Fund
S&P 500
This Quarter
Est. Return
+5.96%
1 Year Est. Return
+26.02%
3 Year Est. Return
+92.08%
5 Year Est. Return
+125.09%
10 Year Est. Return
+457.34%
AUM
$30.1B
AUM Growth
+$3.48B
(+13%)
Cap. Flow
+$2.15B
Cap. Flow
% of AUM
7.12%
Top 10 Holdings %
Top 10 Hldgs %
23.19%
Holding
1,423
New
92
Increased
671
Reduced
310
Closed
81
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$108M |
| 2 |
Salesforce
CRM
|
+$101M |
| 3 |
Johnson & Johnson
JNJ
|
+$93.2M |
| 4 |
Microsoft
MSFT
|
+$89M |
| 5 |
Amazon
AMZN
|
+$75.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$66.1M |
| 2 |
CMS Energy
CMS
|
+$66.1M |
| 3 |
Amgen
AMGN
|
+$65.7M |
| 4 |
Ameren
AEE
|
+$61.6M |
| 5 |
Fidelity National Information Services
FIS
|
+$53.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.74% |
| 2 | Healthcare | 15.88% |
| 3 | Financials | 12.34% |
| 4 | Communication Services | 9.66% |
| 5 | Industrials | 8.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1101
Stoke Therapeutics
STOK
$2.13B
| $328K | ﹤0.01% |
8,900
| – | – |
|
1102
Carlyle Group
CG
$17.4B
| $327K | ﹤0.01% |
8,915
+22
| +0.2% | +$771 |
|
|
MRSN
1103
DELISTED
Mersana Therapeutics
MRSN
| $326K | ﹤0.01% |
840
| – | – |
|
|
ITOS
1104
DELISTED
iTeos Therapeutics
ITOS
| $324K | ﹤0.01% |
10,000
| – | – |
|
1105
Akebia Therapeutics
AKBA
$240M
| $317K | ﹤0.01% |
102,100
| – | – |
|
1106
Bausch Health
BHC
$2.33B
| $315K | ﹤0.01% |
10,203
-700
| -6% | -$20.5K |
|
1107
Encompass Health
EHC
$12.4B
| $315K | ﹤0.01% |
4,777
+3,583
| +300% | +$234K |
|
1108
iQIYI
IQ
$1.3B
| $315K | ﹤0.01% |
17,557
+4,452
| +34% | +$103K |
|
1109
Arcturus Therapeutics
ARCT
$214M
| $314K | ﹤0.01% |
8,100
| – | – |
|
|
RDUS
1110
DELISTED
Radius Health, Inc.
RDUS
| $312K | ﹤0.01% |
15,200
| – | – |
|
|
CNST
1111
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
| $311K | ﹤0.01% |
13,300
| – | – |
|
|
AIV
1112
Aimco
AIV
$376M
| $309K | ﹤0.01% |
50,710
+48,123
| +1,860% | +$244K |
|
1113
Hexcel
HXL
$7.6B
| $309K | ﹤0.01% |
5,460
+2,515
| +85% | +$133K |
|
1114
Precigen
PGEN
$2.46B
| $309K | ﹤0.01% |
46,500
| – | – |
|
1115
Gildan
GIL
$10.8B
| $308K | ﹤0.01% |
10,066
+1,381
| +16% | +$39.4K |
|
1116
Rocket Companies
RKT
$40.5B
| $302K | ﹤0.01% |
+13,107
| New | +$293K |
|
1117
Zions Bancorporation
ZION
$10.4B
| $298K | ﹤0.01% |
5,342
-249
| -4% | -$12.8K |
|
1118
Annexon
ANNX
$875M
| $297K | ﹤0.01% |
12,000
| – | – |
|
1119
Standard Motor Products
SMP
$889M
| $297K | ﹤0.01% |
6,784
+2,987
| +79% | +$127K |
|
1120
Banco Santander Chile
BSAC
$16.5B
| $296K | ﹤0.01% |
12,100
| – | – |
|
1121
Itaú Unibanco
ITUB
$82.7B
| $293K | ﹤0.01% |
82,660
+27,486
| +50% | +$104K |
|
1122
Ovintiv
OVV
$17.6B
| $291K | ﹤0.01% |
12,000
-1,000
| -8% | -$21.4K |
|
1123
Gentherm
THRM
$1.27B
| $285K | ﹤0.01% |
3,942
| – | – |
|
|
RNAM
1124
DELISTED
Avidity Biosciences
RNAM
| $284K | ﹤0.01% |
14,000
| – | – |
|
1125
St. Joe Company
JOE
$3.89B
| $282K | ﹤0.01% |
6,450
| – | – |
|
Similar funds
QCM
NAMI
DekaBank Deutsche Girozentrale's Q1 2021 Portfolio in Review
As of Q1 2021, DekaBank Deutsche Girozentrale held 1,423 positions worth $30.1B, up 13% from $26.6B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
DekaBank Deutsche Girozentrale deployed $2.15B of net new capital in Q1 2021, opening 92 new positions and adding to 671 existing holdings. Its largest new stake was Suzano: 450,000 shares worth $5.55M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was NVIDIA, an estimated $66.1M trimmed.
- DekaBank Deutsche Girozentrale's largest Q1 2021 buy was Suzano: 450,000 shares worth $5.55M.
- DekaBank Deutsche Girozentrale added most to Intel in Q1 2021, an estimated $108M increase.
- DekaBank Deutsche Girozentrale's biggest Q1 2021 reduction was NVIDIA, cutting an estimated $66.1M.
- DekaBank Deutsche Girozentrale fully exited Coherent Inc in Q1 2021, selling an estimated $34.2M.
- DekaBank Deutsche Girozentrale's ten largest holdings make up 23% of its $30.1B portfolio in Q1 2021.
- DekaBank Deutsche Girozentrale opened 92 new positions and closed 81 in Q1 2021.
- DekaBank Deutsche Girozentrale's portfolio value rose 13% quarter-over-quarter to $30.1B.
Based on DekaBank Deutsche Girozentrale's 13F filing for Q1 2021, filed 28 Apr 2021.